TEST:

GuardantREVEAL

Guardant Health will be world's first blood-only liquid biopsy for residual disease detection and recurrence monitoring. Guardant Reveal is based on the LUNAR-1 assay and analyzes thousands of physicians in both the genomic and epigenomic domains to provide a highly actionable and reliable result to oncologists for their early-stage cancer patients and cancer survivors.